Proliferation and aneusomy predict survival of young patients with astrocytoma grade II

British Journal of Cancer

Volumn 89, Issue 1, 2003, Pages 128-134

  Wessels, P H ^a   Hopman, A H N ^b   Kubat, B ^a   Kessels, A G H ^a   Hoving, E W ^c   Ummelen, M I J ^b   Ramaekers, F C S ^b   Twijnstra, A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Aneusomy; Astrocytoma grade II; In situ hybridisation; Ki 67 index; Prognosis; Proliferation

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANEUSOMY; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL PROLIFERATION; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATION INDEX; STEREOTAXIC SURGERY; TUMOR BIOPSY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; CELL DIVISION; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL; TUMOR MARKERS, BIOLOGICAL;

EID: 0042845991     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601067     Document Type: Article

References (34)

1. al-Sarraj S, Bridges LR (1995) p53 immunoreactivity in astrocytomas and its relationship to survival. Br J Neurosurg 9: 143-149
2. Arienti VM, Botturi A, Boiardi A, Broggi G, Collice M, Fariselli L, Zanni D, Botturi M (2001) Adult brain low-grade astrocytomas: survival after surgery and radiotherapy. Neurol Sci 22: 233-238
3. Arnoldus EP, Wolters LBT, Voormolen JHC, van Duinen SG, Raap AK, van der Ploeg M, Peters ACB (1992) Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. J Neurosurg 76: 997-1003
4. Bauman G, Lote K, Larson D, Stalpers L, Leighton C, Fisher B, Wara W, MacDonald D, Stitt L, Cairncross JG (1999) Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis. Int J Radiat Oncol Biol Phys 45: 923-929
5. Berger MS, Deliganis AV, Dobbins J, Keles GE (1994) The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74: 1784-1791
6. Chamberlain MC, Murovic JA, Levin VA (1988) Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 38: 1371-1374
7. Cheng Y, Ng HK, Ding M, Zhang SF, Pang JC, Lo KW (1999) Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. J Neuropathol Exp Neurol 58: 120-128
8. Cianciulli AM, Morace E, Coletta AM, Occhipinti E, Gandolfo GM, Leonardo G, Carapella CM (2000) Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor. J Neurooncol 48: 95-101
9. Cox D (1972) Regression model and life tables. J R Stat Soc Ser B 34: 187-229
10. Fisher BJ, Naumova E, Leighton CC, Naumov GN, Kerklviet N, Fortin D, Macdonald DR, Cairncross JG, Bauman GS, Stitt L (2002) Ki-67: a prognostic factor for low-grade glioma? Int J Radiat Oncol Biol Phys 52: 996-1001
11. Heesters MAAM, Koudstaal J, Go KG, Molenaar WM (1999) Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J Neurooncol 44: 255-266
12. Hopman AHN, Ramaekers FCS (1998) Processing and staining of cell and tissue material for interphase cytogenetics. In Current protocols in cytometry, Robinson P (ed). New York: John Wiley & Sons, Inc (CHAPTER 8.5.1-8.5.2)
13. Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. New York John Wiley & Sons
14. Ito S, Chandler KL, Prados MD, Lamborn K, Wynne J, Malec M, Wilson C, Davis R, Hoshino T (1994) Proliferative potential and prognostic evaluation of low-grade astrocytomas. J Neurooncol 19: 1-9
15. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243
16. Karim ABMF, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, van Glabbeke M (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncot Biol Phys 52: 316-324
17. Karim ABMF, Maat B, Hatlevoll R, Menten J, Rutten EHJ, Thomas DGT, Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ, Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E, Pierart M, van Glabbeke M (1996) A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 36: 549-556
18. Kimmel DW, O'Fallon JR, Scheithauer BW, Kelly PJ, Dewald GW, Jenkins RB (1992) Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol 31: 534-542
19. Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, Seretis A, Thomas-Tsagli E (1997) MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 75: 1269-1278
20. Kleihues P, Cavenee WK (2000) Pathology and Genetics of Tumors of the Nervous Sytem. IARC press: Lyon
21. Kraus JA, Bolln C, Wolf HK, Neumann J, Kindermann D, Fimmers R, Forster F, Baumann A, Schlegel U (1994) TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosomes Cancer 10: 143-149
22. Krouwer HG, Davis RL, Silver P, Prados MD (1991) Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74: 399-406
23. Leighton C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross G (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol 15: 1294-1301
24. Lote K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J, Storm-Mathisen I, Hirschberg H (1997) Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15: 3129-3140
25. McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, Ransohoff J (1992) Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642
26. McKeever PE, Strawderman MS, Yamini B, Mikhail AA, Blaivas M (1998) MIB-1 proliferation index predicts survival among patients with grade II astrocytoma. J Neuropathol Exp Neurol 57: 931-936
27. Recht LD, Lew R, Smith TW (1992) Suspected low-grade glioma: is deferring treatment safe? Ann Neurol 31: 431-436
28. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, Helin HJ (1994) Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 174: 275-282
29. Sallinen SL, Sallinen P, Haapasalo H, Kononen J, Karhu R, Helen P, Isola J (1997) Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas. Am J Pathol 151: 1799-1807
30. Shaw EG, Arusell R, Scheithauer BW, O'Fallon JR, O'Neill B, Dinapoli R, Nelson D, Earle JD, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R (2002) Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 20: 2267-2276
31. Shaw EG, Daumas-Duport C, Scheithauer BW, Gilbertson DT, O'Fallon JR, Earle JD, Laws ER, Okazaki H (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70: 853-861
32. Steilen-Gimbel H, Henn W, Kolles H, Moringlane JR, Feiden W, Steudel WI, Zang KD (1996) Early proliferation enhancement by monosomy 10 and intratumor heterogeneity in malignant human gliomas as revealed by smear preparations from biopsies. Genes Chromosomes Cancer 16: 180-184
33. Vecht CJ (1993) Effect of age on treatment decisions in low-grade glioma. J Neurol Neurosurg Psychiatry 56: 1259-1264
34. Wessels PH, Twijnstra A, Kessels AGH, Krijne-Kubat B, Theunissen PH, Ummelen MIJ, Ramaekers FCS, Hopman AHN (2002) Gain of chromosome 7 as detected by in situ hybridization (ISH) strongly correlates with shorter survival in astrocytoma grade 2. Genes Chromosomes Cancer 33: 279-284